The conversation also delves into the use of GLP-1 agonists and bariatric surgery as treatments for obesity. Dr. Lahlou explains that GLP-1 agonists, initially developed for diabetes treatment, are now used to treat obesity because they help reduce food cravings and manage metabolic disorders. However, she also highlights the challenges, including side effects and the high cost of these medications.